Tan Tock Seng Hospital
Singapore
NCT Number: NCT06704997
The aim of this retrospective study is to ascertain total direct costs, rehabilitation length of stay (RLOS) and factors associated with RLOS for neurological inpatient rehabilitation at the tertiary care hospital.
This study is active but is not currently recruiting participants.
21 year–100 year
All sexes
Observational
Singapore
The aim of the study is to identify factors that influence RLOS and the correlated costs for neurological rehabilitation in tertiary rehab using data extracted from EPIC. It is also aimed to identify the median direct costs to find out the main contributors to the costs in the local population. Lastly, the study aims to utilise artificial intelligence or machine learning to analyse the compiled data to develop a predictive model. The model aspires to understand factors associated with extended RLOS and to predict RLOS of patients who require neurological rehabilitation, aiding preemptive measures.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 1998-2022
Duration of which patient is admitted to and discharge from the rehabilitation ward.
Time frame: 2012-2022
Bill size of patient's stay in the rehabilitation ward, including subsidies, insurance and copayment.
Time frame: 2014-2023
Type of housing to look at the socio-economics status of the patients.
Tan Tock Seng Hospital
Other
Machine Learning Predictive Analysis of Key Factors Influencing Rehabilitation Length of Stay (RLOS) and Direct Hospitalization Costs for Neurological Inpatient Rehabilitation at Tertiary Care Hospital
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07122752
Acquired Brain Injury, Brain Diseases
Singapore
View Trial DetailsNCT05777499
Acquired Brain Injury, Autoimmune Diseases
London, United Kingdom
View Trial DetailsNCT07635329
Blindness, Blindness, Cortical
Washington D.C., District of Columbia, United States
View Trial DetailsNCT07590726
Astrocytoma, Behavior
Copenhagen, Ø, Denmark
View Trial Details